
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NT... AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 4.1095890411 | 1.46 | 1.55 | 1.372 | 125793 | 1.49854464 | CS |
4 | 0.39 | 34.5132743363 | 1.13 | 1.55 | 1.09 | 120295 | 1.31714136 | CS |
12 | 0.16 | 11.7647058824 | 1.36 | 1.55 | 1.0499 | 132346 | 1.22831902 | CS |
26 | 0.46 | 43.3962264151 | 1.06 | 1.675 | 0.975 | 312786 | 1.23040175 | CS |
52 | -1.62 | -51.5923566879 | 3.14 | 3.88 | 0.87 | 362242 | 1.45368466 | CS |
156 | -13.49 | -89.8734177215 | 15.01 | 23.58 | 0.87 | 189281 | 4.26780074 | CS |
260 | -15.33 | -90.9792284866 | 16.85 | 23.58 | 0.87 | 190338 | 4.34437359 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.